Olema Pharmaceuticals Q1 EPS $(0.56) Misses $(0.51) Estimate
Portfolio Pulse from Benzinga Newsdesk
Olema Pharmaceuticals (NASDAQ:OLMA) reported Q1 earnings with losses of $(0.56) per share, missing the consensus estimate of $(0.51) by 9.8%. This represents a 20% improvement over the previous year's losses of $(0.70) per share.
May 08, 2024 | 9:06 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Olema Pharmaceuticals reported a narrower loss in Q1 compared to last year but missed analyst estimates.
Missing analyst estimates, especially in terms of earnings per share (EPS), typically results in negative investor sentiment in the short term. Although the year-over-year improvement in losses indicates progress, the miss may overshadow this positive aspect.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100